Abstract: A battery pack that includes a cell array, a set of first cells of the cell array disposed within the battery pack as one or more first groups of electrically coupled cells, and a set of second cells of the cell array disposed within the module housing as one or more second groups of electrically coupled cells. The set of first cells have a first chemistry, the set of second cells have a second chemistry different from the first chemistry, and the set of first cells are interleaved with the set of second cells inside the battery pack.

Abstract: The present disclosure relates to novel sesquiterpenoid compounds as SHP2 and/or POLE3 inhibitors for potential treatment for cancers, and to methods of making and using the sesquiterpenoid compounds. The present invention therefore provides a method of using the disclosed compounds as chemosensitizations agent to a DNA damaging drugs for cancers.

Abstract: A shareable, wearable training system including a first cuff configured to be worn on an upper arm and/or torso of a user, the first cuff including a first housing defining a first slot and a radio-frequency identification (RFID) transponder sized to fit within the first slot, a second cuff configured to be worn on a lower arm of the user, the second cuff comprising a second housing defining a second slot, and an interchangeable computer system sized to fit within the second slot. The computer system includes a RFID reader and instructions causing the computer system to determine and record whether the RFID transponder is within a threshold distance of the RFID reader and provides the user with a notification when the RFID transponder is within the threshold distance, thereby notifying the user when a distance between a hand of the user and a face of the user is less than the threshold distance.

Abstract: The present disclosure relates to novel sesquiterpenoid compounds as SHP2 and/or POLE3 inhibitors for potential treatment for cancers, and to methods of making and using the sesquiterpenoid compounds. The present invention therefore provides a method of using the disclosed compounds as chemosensitizations agent to a DNA damaging drugs for cancers.

Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.

Abstract: The present disclosure relates to novel sesquiterpenoid compounds as SHP2 and/or POLE3 inhibitors for potential treatment for cancers, and to methods of making and using the sesquiterpenoid compounds. The present invention therefore provides a method of using the disclosed compounds as chemosensitizations agent to a DNA damaging thugs for cancers.

Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.

Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.

Abstract: The present disclosure relates to novel sesquiterpenoid compounds as SHP2 and/or POLE3 inhibitors for potential treatment for cancers, and to methods of making and using the sesquiterpenoid compounds. The present invention therefore provides a method of using the disclosed compounds as chemosensitizations agent to a DNA damaging drugs for cancers.

Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.

Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.

Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.

Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.

Abstract: Systems, methods, and devices directed to a button and corresponding applicator for an animal identification tag are provided. The applicator is employed to attach a button-tag assembly to the ear of an animal. The button includes a solid core embedded in the body of the button as well as a bladed edge at the tip of the core.

Abstract: The present invention provides aryl isonitrile compounds that have antibacterial properties. More specifically, the aryl isonitrile compounds of the present invention are potent inhibitors of drug resistant strains of Staphylococcus aureus.